Effect of insulin and heparin on glucose-induced vascular damage in cell culture

Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is no...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international Vol. 57; no. 6; pp. 2492 - 2501
Main Authors: Mandal, Anil K., Puchalski, Jonathan T., Lemley-Gillespie, Susan, Taylor, Catherine A., Kohno, Masakazu
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-06-2000
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose.
AbstractList Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose.
Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose.
Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and neuropathy. The mechanism of these microvascular complications is not yet fully elucidated. The present study describes the effect of different concentrations of glucose on vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in cell culture. Our objective was to shed some light through this biological study on the mechanism and prevention of diabetic microvascular complications. ECs and VSMCs were treated with 5 mmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL) D-glucose or D-glucose plus insulin or D-glucose plus insulin and heparin in culture. ECs were studied with light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) for surface changes. The cultured ECs were treated with vimentin antibodies and VSMCs with actin antibodies for immunoflourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay was done on ECs culture medium using enzyme-linked immunosorbent assay (ELISA). LM, SEM, and TEM of ECs treated with a physiological concentration (90 mg/dL) of D-glucose appeared the same as control. However, LM and SEM of ECs treated with a high concentration of D-glucose (540 mg/dL) showed pronounced intercellular gaps. This finding was further confirmed by TEM study. These gaps were minimally or not at all discernible when insulin, heparin, or a combination of both was added to the culture medium. IFM showed increased vimentin expression with a high concentration of D-glucose. Vimentin expression was attenuated with the addition of insulin or heparin in the medium and more markedly with combined insulin and heparin. Significant correlations were obtained between glucose levels, vimentin expression, and ET-1 levels. The higher the glucose level, the higher is the ET-1 production and the greater vimentin expression in ECs. Cultured VSMCs treated with a high concentration of D-glucose showed enhanced actin expression. Actin expression was blunted with the addition of insulin or heparin in the culture medium. These biological findings indicate the salutary effect of insulin or insulin and heparin in the mitigation of vascular disorganization caused by a high concentration of D-glucose.
Author Taylor, Catherine A.
Kohno, Masakazu
Mandal, Anil K.
Puchalski, Jonathan T.
Lemley-Gillespie, Susan
Author_xml – sequence: 1
  givenname: Anil K.
  surname: Mandal
  fullname: Mandal, Anil K.
  email: tfischer@med-spec.com
– sequence: 2
  givenname: Jonathan T.
  surname: Puchalski
  fullname: Puchalski, Jonathan T.
– sequence: 3
  givenname: Susan
  surname: Lemley-Gillespie
  fullname: Lemley-Gillespie, Susan
– sequence: 4
  givenname: Catherine A.
  surname: Taylor
  fullname: Taylor, Catherine A.
– sequence: 5
  givenname: Masakazu
  surname: Kohno
  fullname: Kohno, Masakazu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10844618$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1PxCAQholZ437oT9AQ761QoNKjbvxKTPSwd0Jh0G66dIWt0X8vtZuNN09MmOcdmGeOJr7zgBCmJKeEl1frnIqCZfRaiLwghOSEUCLzryM0OzQmaEaIFFkhmJyieYzrBMqKkRM0TTDnJZUz9HrnHJgd7hxufOzbxmPtLX6HrQ6p7jx-a3vTRcgab3sDFn_qaPpWB2z1Rr9BimEDbYvT5a4PcIqOnW4jnO3PBVrd362Wj9nzy8PT8uY5M7ysdlnBtZVWioqw0gDYsqpL4wi7dtJZy0UtbE05tTWnzNWyqFjJwZRguXPcCLZAl-PYbeg-eog7te764NOLqqBJBqsISZAcIRO6GAM4tQ3NRodvRYkaRKq1GnypwZcaRKpfkeorRS_28_t6A_ZPcDSXgPMR8HpY-wBwXlGRNC_Q7diHJOGzgaCiacAng01IwpXtmv9_8QNWsJBS
CitedBy_id crossref_primary_10_1016_j_vph_2013_08_001
crossref_primary_10_4236_ojim_2011_13017
crossref_primary_10_1016_j_trsl_2008_12_007
crossref_primary_10_1186_1475_2840_4_12
crossref_primary_10_1074_jbc_M608565200
crossref_primary_10_1089_ars_2013_5695
crossref_primary_10_1186_1475_2840_8_46
crossref_primary_10_1016_j_ijpharm_2023_122987
crossref_primary_10_1016_j_vph_2014_05_001
crossref_primary_10_1016_j_ijcha_2017_03_004
Cites_doi 10.1161/01.HYP.4.5.681
10.1016/0014-2999(95)00534-X
10.7326/0003-4819-128-7-199804010-00001
10.1016/S0140-6736(95)90403-4
10.1172/JCI116805
10.1007/BF00398060
10.1016/0168-8227(94)90107-4
10.1046/j.1523-1755.1999.00591.x
10.1016/0026-0495(94)90270-4
10.1083/jcb.86.2.688
10.1038/ki.1995.441
10.1002/(SICI)1097-4652(199604)167:1<131::AID-JCP15>3.0.CO;2-E
10.1007/BF02631069
10.1038/ki.1995.147
10.1016/S0140-6736(98)07019-6
10.1681/ASN.V581600
10.1016/0014-5793(90)80276-O
10.1136/bmj.317.7160.703
10.1016/S0022-2143(99)90006-9
10.1055/s-0029-1211724
10.1006/jsre.1994.1195
10.1161/01.HYP.21.3.353
ContentType Journal Article
Copyright 2000 International Society of Nephrology
Copyright Nature Publishing Group Jun 2000
Copyright_xml – notice: 2000 International Society of Nephrology
– notice: Copyright Nature Publishing Group Jun 2000
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QP
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.1046/j.1523-1755.2000.00108.x
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList
MEDLINE
ProQuest One Academic Eastern Edition
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1523-1755
EndPage 2501
ExternalDocumentID 980026251
10_1046_j_1523_1755_2000_00108_x
10844618
4491589
S0085253815470085
Genre Journal Article
GroupedDBID ---
.55
.GJ
0R~
1CY
29L
2WC
36B
39C
3O-
3V.
4.4
457
53G
5GY
5RE
5VS
6I.
6PF
7RV
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACTN
AAEDW
AAFTH
AAIAV
AAKUH
AALRI
AAQFI
AAWTL
AAXUO
ABAWZ
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ABVKL
ACGFO
ACGFS
ACPRK
ADBBV
ADEZE
ADFRT
ADQMX
AENEX
AEXQZ
AFEBI
AFKRA
AFTJW
AGHFR
AHMBA
AHPSJ
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BENPR
BFHJK
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DU5
EBS
EJD
EX3
F5P
FDB
FRP
FYUFA
GX1
HMCUK
HZ~
IHE
J5H
JSO
KQ8
L7B
LH4
LW6
M1P
M41
MJL
N4W
NAPCQ
NCXOZ
O9-
OK1
P2P
P6G
PQQKQ
PROAC
PSQYO
Q2X
R9-
RIG
RNS
ROL
SDH
SSZ
TR2
UKHRP
W2D
WOW
X7M
XVB
YFH
YOC
YUY
ZA5
ZCG
ZGI
ZXP
-
08R
0R
55
ABFLS
ABPTK
ADBIT
AFETI
BBAFP
GJ
HZ
IPNFZ
PQEST
PQUKI
PRINS
XIP
0SF
ADVLN
AFJKZ
AKRWK
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7XB
8FK
K9.
ID FETCH-LOGICAL-c469t-24ad8d859036ceed69b6cf037f8fdd45b5db141db413fb829364ec6ed4ff4c53
ISSN 0085-2538
IngestDate Thu Oct 10 15:57:33 EDT 2024
Thu Nov 21 22:38:28 EST 2024
Sat Sep 28 07:35:37 EDT 2024
Thu Oct 07 19:41:09 EDT 2021
Fri Feb 23 02:12:32 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords diabetic vascular complications
endothelial cells
D-glucose
cell adhesion
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c469t-24ad8d859036ceed69b6cf037f8fdd45b5db141db413fb829364ec6ed4ff4c53
OpenAccessLink https://dx.doi.org/10.1046/j.1523-1755.2000.00108.x
PMID 10844618
PQID 210103900
PQPubID 47198
PageCount 10
ParticipantIDs proquest_journals_210103900
crossref_primary_10_1046_j_1523_1755_2000_00108_x
pubmed_primary_10844618
nature_primary_4491589
elsevier_sciencedirect_doi_10_1046_j_1523_1755_2000_00108_x
ProviderPackageCode ADQMX
PublicationCentury 2000
PublicationDate 2000-06-01
PublicationDateYYYYMMDD 2000-06-01
PublicationDate_xml – month: 06
  year: 2000
  text: 2000-06-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Kidney international
PublicationTitleAlternate Kidney Int
PublicationYear 2000
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Mueller, Fritsche, Haslinger, Landgraf (bb0070) 1997; 105
Sank, Wei, Reid (bb0010) 1994; 57
Rosenzweig, Kanwar (bb0105) 1982; 47
Curcio, Ceriello (bb0020) 1992; 28A
Metsarinne, Saijonmaa, Yki-Jarvinen, Fyhrquist (bb0080) 1994; 43
Kamoi, Ishibashi, Yamaji (bb0015) 1994; 24
Imai, Hirata, Emori, Marumo (bb0090) 1993; 21
Kobayashi, Ishida, Moriya, Mori, Fukuda, Takamura (bb0135) 1999; 133
Yokoyama, Sato, Dkudaira, Morita, Takahashi, Suzuki, Sakai, Iwamoto (bb0125) 1999; 56
Ferri, Pittoni, Piccoli, Laurenti, Cassons, Bellinic Properzi, Valesini, Demattia, Santucci (bb0100) 1995; 80
Kanwar, Linker, Farquhar (bb0110) 1980; 86
Kasinath, Grellier, Ghosh Choudhury, Abboud (bb0120) 1996; 167
Inoguchi, Xia, Kunisuki, Higashi, Feener, King (bb0095) 1994; 267
Susic, Mandal, Radjkovic, Vulovic, Kentera (bb0145) 1988; 111
UK Prospective Diabetes Study Group (bb0035) 1998; 317
Tamsma, Vandenborn, Bruijin, Assinan, Weening, Berden, Wieslander, Shrama, Hermans, Veerkamp, Lenkes, Vander Woude (bb0115) 1994; 37
Yokokawa, Tahara, Kohno, Mandal, Yanagisawa, Takeda (bb0055) 1993; 92
Myrup, Hansen, Jensen, Kefoed-Eneroldsen, Feldt-Rasmussen, Gram, Kluft, Jespersen, Deckert (bb0130) 1995; 345
Susic, Mandal, Kentera (bb0140) 1982; 4
Mandal, Lyden, Saklayen (bb0040) 1995; 47
Graier, Grubnethal, Dittrich, Wuscher, Kestner (bb0060) 1995; 294
UK Prospective Diabetics Study Group (bb0030) 1998; 352
Takeuchi, Throckmorton, Brogden, Yoshizawa, Rasmussen, Kashgarian (bb0065) 1995; 268
Mandal, Lyden, Fazel, Saklayen, Mehrotra, Mahling, Taylor, Yokokawa, Colvin (bb0045) 1995; 48
Yokokawa, Mandal, Kohno, Horio, Murakawa, Yasunari, Takeda (bb0050) 1992; 263
The Diabetes Control Complications Trial Research Group (bb0025) 1998; 128
Cosio (bb0075) 1995; 5
Yamauchi, Ohnaka, Takayanagi, Umeda, Nawata (bb0085) 1990; 267
Kanwar, YS, Linker, A, Farquhar, MG 1980; 86
Takeuchi, A, Throckmorton, DC, Brogden, AP, Yoshizawa, N, Rasmussen, H, Kashgarian, M 1995; 268
Myrup, B, Hansen, PM, Jensen, T, Kefoed-Eneroldsen, A, Feldt-Rasmussen, B, Gram, J, Kluft, C, Jespersen, J, Deckert, T 1995; 345
1998; 317
Kamoi, K, Ishibashi, M, Yamaji, T 1994; 24
Curcio, A, Ceriello, A 1992; 28A
Yokokawa, K, Mandal, AK, Kohno, M, Horio, T, Murakawa, K, Yasunari, K, Takeda, T 1992; 263
1998; 352
Metsarinne, K, Saijonmaa, O, Yki-Jarvinen, H, Fyhrquist, F 1994; 43
Susic, D, Mandal, AK, Kentera, D 1982; 4
Imai, T, Hirata, Y, Emori, T, Marumo, F 1993; 21
Ferri, C, Pittoni, V, Piccoli, A, Laurenti, O, Cassons, MR, Bellinic Properzi, G, Valesini, G, Demattia, G, Santucci, A 1995; 80
Kasinath, BS, Grellier, P, Ghosh Choudhury, G, Abboud, SL 1996; 167
Inoguchi, T, Xia, P, Kunisuki, M, Higashi, S, Feener, EP, King, GL 1994; 267
Mandal, AK, Lyden, TW, Saklayen, MG 1995; 47
Tamsma, JT, Vandenborn, J, Bruijin, JA, Assinan, KJM, Weening, JJ, Berden, JHM, Wieslander, J, Shrama, E, Hermans, J, Veerkamp, JH, Lenkes, HHPJ, Vander Woude, FJ 1994; 37
Kobayashi, S, Ishida, A, Moriya, TT, Mori, N, Fukuda, T, Takamura, T 1999; 133
Mandal, AK, Lyden, TW, Fazel, A, Saklayen, MG, Mehrotra, B, Mahling, B, Taylor, CA, Yokokawa, K, Colvin, RB 1995; 48
Yokokawa, K, Tahara, H, Kohno, M, Mandal, AK, Yanagisawa, M, Takeda, T 1993; 92
Susic, D, Mandal, AK, Radjkovic, G, Vulovic, D, Kentera, D 1988; 111
Cosio, F 1995; 5
Yokoyama, H, Sato, K, Dkudaira, M, Morita, C, Takahashi, C, Suzuki, D, Sakai, H, Iwamoto, Y 1999; 56
Rosenzweig, LJ, Kanwar, YS 1982; 47
1998; 128
Yamauchi, T, Ohnaka, K, Takayanagi, R, Umeda, F, Nawata, H 1990; 267
Graier, WF, Grubnethal, I, Dittrich, P, Wuscher, TC, Kestner, GM 1995; 294
Sank, A, Wei, D, Reid, J 1994; 57
Mueller, HK, Fritsche, U, Haslinger, A, Landgraf, R 1997; 105
Metsarinne (10.1046/j.1523-1755.2000.00108.x_bb0080) 1994; 43
Susic (10.1046/j.1523-1755.2000.00108.x_bb0145) 1988; 111
Kobayashi (10.1046/j.1523-1755.2000.00108.x_bb0135) 1999; 133
Yokoyama (10.1046/j.1523-1755.2000.00108.x_bb0125) 1999; 56
Myrup (10.1046/j.1523-1755.2000.00108.x_bb0130) 1995; 345
Sank (10.1046/j.1523-1755.2000.00108.x_bb0010) 1994; 57
Takeuchi (10.1046/j.1523-1755.2000.00108.x_bb0065) 1995; 268
Tamsma (10.1046/j.1523-1755.2000.00108.x_bb0115) 1994; 37
Mueller (10.1046/j.1523-1755.2000.00108.x_bb0070) 1997; 105
Mandal (10.1046/j.1523-1755.2000.00108.x_bb0045) 1995; 48
Curcio (10.1046/j.1523-1755.2000.00108.x_bb0020) 1992; 28A
Mandal (10.1046/j.1523-1755.2000.00108.x_bb0040) 1995; 47
Cosio (10.1046/j.1523-1755.2000.00108.x_bb0075) 1995; 5
Rosenzweig (10.1046/j.1523-1755.2000.00108.x_bb0105) 1982; 47
Ferri (10.1046/j.1523-1755.2000.00108.x_bb0100) 1995; 80
UK Prospective Diabetics Study Group (10.1046/j.1523-1755.2000.00108.x_bb0030) 1998; 352
Yokokawa (10.1046/j.1523-1755.2000.00108.x_bb0055) 1993; 92
Imai (10.1046/j.1523-1755.2000.00108.x_bb0090) 1993; 21
Graier (10.1046/j.1523-1755.2000.00108.x_bb0060) 1995; 294
Yamauchi (10.1046/j.1523-1755.2000.00108.x_bb0085) 1990; 267
Yokokawa (10.1046/j.1523-1755.2000.00108.x_bb0050) 1992; 263
Inoguchi (10.1046/j.1523-1755.2000.00108.x_bb0095) 1994; 267
Susic (10.1046/j.1523-1755.2000.00108.x_bb0140) 1982; 4
Kasinath (10.1046/j.1523-1755.2000.00108.x_bb0120) 1996; 167
Kanwar (10.1046/j.1523-1755.2000.00108.x_bb0110) 1980; 86
Kamoi (10.1046/j.1523-1755.2000.00108.x_bb0015) 1994; 24
The Diabetes Control Complications Trial Research Group (10.1046/j.1523-1755.2000.00108.x_bb0025) 1998; 128
UK Prospective Diabetes Study Group (10.1046/j.1523-1755.2000.00108.x_bb0035) 1998; 317
References_xml – volume: 24
  start-page: 125
  year: 1994
  end-page: 129
  ident: bb0015
  article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy
  publication-title: Diabetes Res Clin Pract
  contributor:
    fullname: Yamaji
– volume: 128
  start-page: 517
  year: 1998
  end-page: 523
  ident: bb0025
  article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial
  publication-title: Ann Intern Med
  contributor:
    fullname: The Diabetes Control Complications Trial Research Group
– volume: 80
  start-page: 829
  year: 1995
  end-page: 835
  ident: bb0100
  article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Santucci
– volume: 56
  start-page: 650
  year: 1999
  end-page: 658
  ident: bb0125
  article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy
  publication-title: Kidney Int
  contributor:
    fullname: Iwamoto
– volume: 294
  start-page: 221
  year: 1995
  end-page: 229
  ident: bb0060
  article-title: Intracellular mechanism of high
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Kestner
– volume: 268
  start-page: F13
  year: 1995
  end-page: F19
  ident: bb0065
  article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells
  publication-title: Am J Physiol
  contributor:
    fullname: Kashgarian
– volume: 37
  start-page: 313
  year: 1994
  end-page: 320
  ident: bb0115
  article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane
  publication-title: Diabetologia
  contributor:
    fullname: Vander Woude
– volume: 47
  start-page: 1017
  year: 1995
  end-page: 1022
  ident: bb0040
  article-title: Heparin lowers blood pressure: Biological and clinical perspectives
  publication-title: Kidney Int
  contributor:
    fullname: Saklayen
– volume: 167
  start-page: 131
  year: 1996
  end-page: 136
  ident: bb0120
  article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium
  publication-title: J Cell Physiol
  contributor:
    fullname: Abboud
– volume: 48
  start-page: 1508
  year: 1995
  end-page: 1516
  ident: bb0045
  article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation
  publication-title: Kidney Int
  contributor:
    fullname: Colvin
– volume: 267
  start-page: 16
  year: 1990
  end-page: 18
  ident: bb0085
  article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell
  publication-title: FEBS Lett
  contributor:
    fullname: Nawata
– volume: 92
  start-page: 2080
  year: 1993
  end-page: 2085
  ident: bb0055
  article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells
  publication-title: J Clin Invest
  contributor:
    fullname: Takeda
– volume: 21
  start-page: 353
  year: 1993
  end-page: 358
  ident: bb0090
  article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells
  publication-title: Hypertension
  contributor:
    fullname: Marumo
– volume: 4
  start-page: 681
  year: 1982
  end-page: 685
  ident: bb0140
  article-title: Heparin lowers blood pressure in hypertensive rats
  publication-title: Hypertension
  contributor:
    fullname: Kentera
– volume: 57
  start-page: 647
  year: 1994
  end-page: 653
  ident: bb0010
  article-title: Human endothelial cells are defective in diabetic vascular disease
  publication-title: J Surg Res
  contributor:
    fullname: Reid
– volume: 263
  start-page: R1035
  year: 1992
  end-page: R1041
  ident: bb0050
  article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats
  publication-title: Am J Physiol
  contributor:
    fullname: Takeda
– volume: 28A
  start-page: 787
  year: 1992
  end-page: 790
  ident: bb0020
  article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications
  publication-title: In Vitro Cell Dev Biol
  contributor:
    fullname: Ceriello
– volume: 317
  start-page: 703
  year: 1998
  end-page: 713
  ident: bb0035
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  publication-title: Br Med J
  contributor:
    fullname: UK Prospective Diabetes Study Group
– volume: 86
  start-page: 688
  year: 1980
  end-page: 693
  ident: bb0110
  article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion
  publication-title: J Cell Biol
  contributor:
    fullname: Farquhar
– volume: 352
  start-page: 837
  year: 1998
  end-page: 853
  ident: bb0030
  article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
  publication-title: Lancet
  contributor:
    fullname: UK Prospective Diabetics Study Group
– volume: 111
  start-page: 63
  year: 1988
  end-page: 72
  ident: bb0145
  article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats
  publication-title: J Lab Clin Med
  contributor:
    fullname: Kentera
– volume: 267
  start-page: E369
  year: 1994
  end-page: E379
  ident: bb0095
  article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue
  publication-title: Am J Physiol
  contributor:
    fullname: King
– volume: 47
  start-page: 177
  year: 1982
  end-page: 184
  ident: bb0105
  article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to
  publication-title: Lab Invest
  contributor:
    fullname: Kanwar
– volume: 345
  start-page: 421
  year: 1995
  end-page: 422
  ident: bb0130
  article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus
  publication-title: Lancet
  contributor:
    fullname: Deckert
– volume: 133
  start-page: 134
  year: 1999
  end-page: 143
  ident: bb0135
  article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change
  publication-title: J Lab Clin Med
  contributor:
    fullname: Takamura
– volume: 5
  start-page: 1600
  year: 1995
  end-page: 1609
  ident: bb0075
  article-title: Effects of high glucose concentrations on human mesangial cell proliferation
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Cosio
– volume: 43
  start-page: 878
  year: 1994
  end-page: 882
  ident: bb0080
  article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo
  publication-title: Metabolism
  contributor:
    fullname: Fyhrquist
– volume: 105
  start-page: 32
  year: 1997
  end-page: 38
  ident: bb0070
  article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C
  publication-title: Exp Clin Endocrinol Diabetes
  contributor:
    fullname: Landgraf
– volume: 128
  start-page: 517
  year: 1998
  end-page: 523
  article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial.
  publication-title: Ann Intern Med
– volume: 47
  start-page: 1017
  year: 1995
  end-page: 1022
  article-title: Heparin lowers blood pressure: Biological and clinical perspectives.
  publication-title: Kidney Int
  contributor:
    fullname: Saklayen, MG
– volume: 352
  start-page: 837
  year: 1998
  end-page: 853
  article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
  publication-title: Lancet
– volume: 111
  start-page: 63
  year: 1988
  end-page: 72
  article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats.
  publication-title: J Lab Clin Med
  contributor:
    fullname: Kentera, D
– volume: 28A
  start-page: 787
  year: 1992
  end-page: 790
  article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications.
  publication-title: In Vitro Cell Dev Biol
  contributor:
    fullname: Ceriello, A
– volume: 43
  start-page: 878
  year: 1994
  end-page: 882
  article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo.
  publication-title: Metabolism
  contributor:
    fullname: Fyhrquist, F
– volume: 56
  start-page: 650
  year: 1999
  end-page: 658
  article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy.
  publication-title: Kidney Int
  contributor:
    fullname: Iwamoto, Y
– volume: 47
  start-page: 177
  year: 1982
  end-page: 184
  article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to I albumin.
  publication-title: Lab Invest
  contributor:
    fullname: Kanwar, YS
– volume: 268
  start-page: F13
  year: 1995
  end-page: F19
  article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells.
  publication-title: Am J Physiol
  contributor:
    fullname: Kashgarian, M
– volume: 37
  start-page: 313
  year: 1994
  end-page: 320
  article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane.
  publication-title: Diabetologia
  contributor:
    fullname: Vander Woude, FJ
– volume: 267
  start-page: E369
  year: 1994
  end-page: E379
  article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue.
  publication-title: Am J Physiol
  contributor:
    fullname: King, GL
– volume: 133
  start-page: 134
  year: 1999
  end-page: 143
  article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change.
  publication-title: J Lab Clin Med
  contributor:
    fullname: Takamura, T
– volume: 24
  start-page: 125
  year: 1994
  end-page: 129
  article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy.
  publication-title: Diabetes Res Clin Pract
  contributor:
    fullname: Yamaji, T
– volume: 92
  start-page: 2080
  year: 1993
  end-page: 2085
  article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells.
  publication-title: J Clin Invest
  contributor:
    fullname: Takeda, T
– volume: 86
  start-page: 688
  year: 1980
  end-page: 693
  article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion.
  publication-title: J Cell Biol
  contributor:
    fullname: Farquhar, MG
– volume: 48
  start-page: 1508
  year: 1995
  end-page: 1516
  article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation.
  publication-title: Kidney Int
  contributor:
    fullname: Colvin, RB
– volume: 57
  start-page: 647
  year: 1994
  end-page: 653
  article-title: Human endothelial cells are defective in diabetic vascular disease.
  publication-title: J Surg Res
  contributor:
    fullname: Reid, J
– volume: 4
  start-page: 681
  year: 1982
  end-page: 685
  article-title: Heparin lowers blood pressure in hypertensive rats.
  publication-title: Hypertension
  contributor:
    fullname: Kentera, D
– volume: 267
  start-page: 16
  year: 1990
  end-page: 18
  article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell.
  publication-title: FEBS Lett
  contributor:
    fullname: Nawata, H
– volume: 167
  start-page: 131
  year: 1996
  end-page: 136
  article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
  publication-title: J Cell Physiol
  contributor:
    fullname: Abboud, SL
– volume: 80
  start-page: 829
  year: 1995
  end-page: 835
  article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Santucci, A
– volume: 21
  start-page: 353
  year: 1993
  end-page: 358
  article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells.
  publication-title: Hypertension
  contributor:
    fullname: Marumo, F
– volume: 5
  start-page: 1600
  year: 1995
  end-page: 1609
  article-title: Effects of high glucose concentrations on human mesangial cell proliferation.
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Cosio, F
– volume: 105
  start-page: 32
  year: 1997
  end-page: 38
  article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C.
  publication-title: Exp Clin Endocrinol Diabetes
  contributor:
    fullname: Landgraf, R
– volume: 294
  start-page: 221
  year: 1995
  end-page: 229
  article-title: Intracellular mechanism of high -glucose-induced modulation of vascular proliferation.
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Kestner, GM
– volume: 345
  start-page: 421
  year: 1995
  end-page: 422
  article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus.
  publication-title: Lancet
  contributor:
    fullname: Deckert, T
– volume: 263
  start-page: R1035
  year: 1992
  end-page: R1041
  article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats.
  publication-title: Am J Physiol
  contributor:
    fullname: Takeda, T
– volume: 317
  start-page: 703
  year: 1998
  end-page: 713
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.
  publication-title: Br Med J
– volume: 4
  start-page: 681
  year: 1982
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0140
  article-title: Heparin lowers blood pressure in hypertensive rats
  publication-title: Hypertension
  doi: 10.1161/01.HYP.4.5.681
  contributor:
    fullname: Susic
– volume: 294
  start-page: 221
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0060
  article-title: Intracellular mechanism of high D-glucose-induced modulation of vascular proliferation
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(95)00534-X
  contributor:
    fullname: Graier
– volume: 267
  start-page: E369
  year: 1994
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0095
  article-title: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue
  publication-title: Am J Physiol
  contributor:
    fullname: Inoguchi
– volume: 128
  start-page: 517
  year: 1998
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0025
  article-title: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-128-7-199804010-00001
  contributor:
    fullname: The Diabetes Control Complications Trial Research Group
– volume: 47
  start-page: 177
  year: 1982
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0105
  article-title: Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I albumin
  publication-title: Lab Invest
  contributor:
    fullname: Rosenzweig
– volume: 345
  start-page: 421
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0130
  article-title: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)90403-4
  contributor:
    fullname: Myrup
– volume: 92
  start-page: 2080
  year: 1993
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0055
  article-title: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI116805
  contributor:
    fullname: Yokokawa
– volume: 37
  start-page: 313
  year: 1994
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0115
  article-title: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane
  publication-title: Diabetologia
  doi: 10.1007/BF00398060
  contributor:
    fullname: Tamsma
– volume: 24
  start-page: 125
  year: 1994
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0015
  article-title: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/0168-8227(94)90107-4
  contributor:
    fullname: Kamoi
– volume: 56
  start-page: 650
  year: 1999
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0125
  article-title: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.00591.x
  contributor:
    fullname: Yokoyama
– volume: 43
  start-page: 878
  year: 1994
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0080
  article-title: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo
  publication-title: Metabolism
  doi: 10.1016/0026-0495(94)90270-4
  contributor:
    fullname: Metsarinne
– volume: 86
  start-page: 688
  year: 1980
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0110
  article-title: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion
  publication-title: J Cell Biol
  doi: 10.1083/jcb.86.2.688
  contributor:
    fullname: Kanwar
– volume: 80
  start-page: 829
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0100
  article-title: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Ferri
– volume: 48
  start-page: 1508
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0045
  article-title: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation
  publication-title: Kidney Int
  doi: 10.1038/ki.1995.441
  contributor:
    fullname: Mandal
– volume: 111
  start-page: 63
  year: 1988
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0145
  article-title: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats
  publication-title: J Lab Clin Med
  contributor:
    fullname: Susic
– volume: 167
  start-page: 131
  year: 1996
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0120
  article-title: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium
  publication-title: J Cell Physiol
  doi: 10.1002/(SICI)1097-4652(199604)167:1<131::AID-JCP15>3.0.CO;2-E
  contributor:
    fullname: Kasinath
– volume: 28A
  start-page: 787
  year: 1992
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0020
  article-title: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications
  publication-title: In Vitro Cell Dev Biol
  doi: 10.1007/BF02631069
  contributor:
    fullname: Curcio
– volume: 47
  start-page: 1017
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0040
  article-title: Heparin lowers blood pressure: Biological and clinical perspectives
  publication-title: Kidney Int
  doi: 10.1038/ki.1995.147
  contributor:
    fullname: Mandal
– volume: 352
  start-page: 837
  year: 1998
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0030
  article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07019-6
  contributor:
    fullname: UK Prospective Diabetics Study Group
– volume: 263
  start-page: R1035
  year: 1992
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0050
  article-title: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats
  publication-title: Am J Physiol
  contributor:
    fullname: Yokokawa
– volume: 268
  start-page: F13
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0065
  article-title: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells
  publication-title: Am J Physiol
  contributor:
    fullname: Takeuchi
– volume: 5
  start-page: 1600
  year: 1995
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0075
  article-title: Effects of high glucose concentrations on human mesangial cell proliferation
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V581600
  contributor:
    fullname: Cosio
– volume: 267
  start-page: 16
  year: 1990
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0085
  article-title: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)80276-O
  contributor:
    fullname: Yamauchi
– volume: 317
  start-page: 703
  year: 1998
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0035
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  publication-title: Br Med J
  doi: 10.1136/bmj.317.7160.703
  contributor:
    fullname: UK Prospective Diabetes Study Group
– volume: 133
  start-page: 134
  year: 1999
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0135
  article-title: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change
  publication-title: J Lab Clin Med
  doi: 10.1016/S0022-2143(99)90006-9
  contributor:
    fullname: Kobayashi
– volume: 105
  start-page: 32
  year: 1997
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0070
  article-title: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C
  publication-title: Exp Clin Endocrinol Diabetes
  doi: 10.1055/s-0029-1211724
  contributor:
    fullname: Mueller
– volume: 57
  start-page: 647
  year: 1994
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0010
  article-title: Human endothelial cells are defective in diabetic vascular disease
  publication-title: J Surg Res
  doi: 10.1006/jsre.1994.1195
  contributor:
    fullname: Sank
– volume: 21
  start-page: 353
  year: 1993
  ident: 10.1046/j.1523-1755.2000.00108.x_bb0090
  article-title: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells
  publication-title: Hypertension
  doi: 10.1161/01.HYP.21.3.353
  contributor:
    fullname: Imai
SSID ssj0008930
Score 1.7467865
Snippet Effect of insulin and heparin on glucose-induced vascular damage in cell culture. Clinical trials have shown that tight glycemic control reduces the risk of...
Clinical trials have shown that tight glycemic control reduces the risk of diabetic microvascular complications, namely retinopathy, nephropathy, and...
SourceID proquest
crossref
pubmed
nature
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2492
SubjectTerms cell adhesion
Cell Line
D-glucose
diabetic vascular complications
endothelial cells
Endothelin-1 - metabolism
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Endothelium, Vascular - pathology
Fluorescent Antibody Technique
Glucose - pharmacology
Heparin - pharmacology
Insulin - pharmacology
Microscopy, Electron
Microscopy, Electron, Scanning
Osmolar Concentration
Vascular Diseases - chemically induced
Vascular Diseases - metabolism
Vascular Diseases - pathology
Title Effect of insulin and heparin on glucose-induced vascular damage in cell culture
URI https://dx.doi.org/10.1046/j.1523-1755.2000.00108.x
http://dx.doi.org/10.1046/j.1523-1755.2000.00108.x
https://www.ncbi.nlm.nih.gov/pubmed/10844618
https://www.proquest.com/docview/210103900
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3di9NAEF96J4gv4tdpPZV98K1sSdLd7QafDq2eVEWwD76FZHfD9fDSw15B_3tn9itGK5yILyGk5Gvm18nM7MxvCHmuBEfSkYZpXbaM65qzupg1TOhaFxZCucw1Cp9-mn_4rF4t-GI0iqOf-mP_VdNwDHSNnbN_oe10UTgA-6Bz2ILWYXstvQc6YscE4cvMMTV-ZnHaYIdLA6FInUEwvsPF_1SLauoLLODBwnRM6HlOjkGl0HJtOvvdUUykLGKf0obg3q_4d-svk-U0Gd2dPoO39uOxY7J-skq_v7MXYJjYG2xK3F6uf68V6pMKqV1xcjIdpCuyvqzK59BiH82gzBMdP1YIz_MytcEUF0ie6kl8o632ZNYBkwPDy_1IvfARB8cu3_uByBwz8vk0Xd31KuF6VKZi4eiAfhtbyQU-Gviac9w_IDcKMGoufH-7TF998Pt8u1N4k1A1FlbQ997tj67QgNN1T8zjfJ_VHXI7BC30xKPtLhnZ7h65-T6UZdwnHz3o6KalAXQU0EAD6Oimo7-AjkbQUQ86OI0i6GgA3QOyer1YvTxlYVQH01yWV6zgtVFGiRIcInS7ZNlI3WazeataY7hohGlynpsGfKa2UeBjSm61tIa3LddidkQOu01nH4HQcmlAzrrQ4FzOpCglBMBwgbLRRsJ5Y5JHoVWXnpClcoUUHJsOUdAVChrHqyLxLQi6-jYmL6J0q-BYeoexAlhc4-wjr5B0PzBvuVDlmBxHBVXBAmyrIsfJKWWWjclDr7OfHlNxLnP1-J8e55jc6v9XT8jh1dedfUoOtmb3zCHyBxmrsRM
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+insulin+and+heparin+on+glucose-induced+vascular+damage+in+cell+culture&rft.jtitle=Kidney+international&rft.au=Mandal%2C+Anil+K.&rft.au=Puchalski%2C+Jonathan+T.&rft.au=Lemley-Gillespie%2C+Susan&rft.au=Taylor%2C+Catherine+A.&rft.date=2000-06-01&rft.pub=Elsevier+Inc&rft.issn=0085-2538&rft.eissn=1523-1755&rft.volume=57&rft.issue=6&rft.spage=2492&rft.epage=2501&rft_id=info:doi/10.1046%2Fj.1523-1755.2000.00108.x&rft.externalDocID=S0085253815470085
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0085-2538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0085-2538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0085-2538&client=summon